Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

NCT06545695 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06545695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06545695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
Lead sponsor
Northwestern University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
July 1, 2027
Completion date
June 30, 2031
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolytic ichthyosis, pachyonychia congenita, palmoplantar keratoderma